% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • upward2000 upward2000 Oct 17, 2012 11:47 PM Flag

    Hep C Multi-Billion Dollar Market & Growing Fast

    ABT the Leader and Winner--on to $80s in 2013 --Easy

    The regimen with the highest SVR12 rates contained the Abbott experimental drugs--ABT-450 with ritonavir, ABT-267 and ABT-333--plus ribavirin for 12 weeks.

    This regimen led to an SVR12 rate of 99% in 77 patients who hadn't received prior treatment, and 93% among 41 patients who hadn't responded well to therapy containing the injectable drug interferon.

    Read more:

    Sentiment: Strong Buy

40.41-0.09(-0.22%)Oct 24 4:00 PMEDT